Rights and permissions
About this article
Cite this article
Nesiritide reduces LOS, costs in heart failure vs milrinone. Pharmacoecon. Outcomes News 436, 5 (2003). https://doi.org/10.1007/BF03276960
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03276960